These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31060092)

  • 1. Role of Pharmacologic Paralysis in Acute Respiratory Distress Syndrome.
    Syed A; Kobzik A; Huang DT
    Semin Respir Crit Care Med; 2019 Feb; 40(1):101-113. PubMed ID: 31060092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
    Mefford B; Donaldson JC; Bissell BD
    Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
    [No Abstract]   [Full Text] [Related]  

  • 3. Association Between Train-of-Four Values and Gas Exchange Indices in Moderate to Severe Acute Respiratory Distress Syndrome.
    Groetzinger LM; Rivosecchi RM; Kane-Gill SL; Donahoe MP
    Ann Pharmacother; 2016 Dec; 50(12):1009-1015. PubMed ID: 27511813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of neuromuscular blockade: a comparison of train-of-four and the Campbell diagram.
    Baedorf Kassis E; Train S; MacNeil B; Loring SH; Talmor D
    Intensive Care Med; 2018 Dec; 44(12):2305-2306. PubMed ID: 30350170
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of paralytics in patients with acute respiratory distress syndrome.
    Hraiech S; Dizier S; Papazian L
    Clin Chest Med; 2014 Dec; 35(4):753-63. PubMed ID: 25453423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade Trial for Acute Respiratory Distress Syndrome.
    Huang DT; Angus DC; Moss M; Thompson BT; Ferguson ND; Ginde A; Gong MN; Gundel S; Hayden DL; Hite RD; Hou PC; Hough CL; Iwashyna TJ; Liu KD; Talmor DS; Yealy DM;
    Ann Am Thorac Soc; 2017 Jan; 14(1):124-133. PubMed ID: 27779896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular Blockade Applicability in Early Acute Respiratory Distress Syndrome.
    Hurford WE
    Anesthesiology; 2020 Jun; 132(6):1577-1584. PubMed ID: 32032097
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.
    Murray MJ; DeBlock H; Erstad B; Gray A; Jacobi J; Jordan C; McGee W; McManus C; Meade M; Nix S; Patterson A; Sands MK; Pino R; Tescher A; Arbour R; Rochwerg B; Murray CF; Mehta S
    Crit Care Med; 2016 Nov; 44(11):2079-2103. PubMed ID: 27755068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of neuromuscular blocking agents in the ICU: where are we now?
    Greenberg SB; Vender J
    Crit Care Med; 2013 May; 41(5):1332-44. PubMed ID: 23591211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome.
    Macario A; Chow JL; Dexter F
    BMC Med Inform Decis Mak; 2006 Mar; 6():15. PubMed ID: 16539706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient.
    deBacker J; Hart N; Fan E
    Chest; 2017 Mar; 151(3):697-706. PubMed ID: 27818334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterotopic ossification due to neuromuscular blocking agent in adult respiratory distress syndrome. A case report.
    Zynnurodlu M; Kaymak Karatap G; Sepycy V
    Eur J Phys Rehabil Med; 2008 Mar; 44(1):81-5. PubMed ID: 18385631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of neuromuscular blocking agents and reversal of blockade: guidelines from Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor].
    Alvarez Gómez JA; Ariño Irujo JJ; Errando Oyonarte CL; Matínez Torrente F; Roigé i Solé J; Gilsanz Rodríguez F;
    Rev Esp Anestesiol Reanim; 2009 Dec; 56(10):616-27. PubMed ID: 20151524
    [No Abstract]   [Full Text] [Related]  

  • 14. Intensive care unit drug use and subsequent quality of life in acute lung injury patients.
    Nelson BJ; Weinert CR; Bury CL; Marinelli WA; Gross CR
    Crit Care Med; 2000 Nov; 28(11):3626-30. PubMed ID: 11098964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for acute respiratory distress syndrome.
    Shafeeq H; Lat I
    Pharmacotherapy; 2012 Oct; 32(10):943-57. PubMed ID: 23033233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    Brink M; Everaars N; de Pont AJM
    N Engl J Med; 2019 Aug; 381(8):785. PubMed ID: 31433931
    [No Abstract]   [Full Text] [Related]  

  • 17. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    Aquino Esperanza J; de Haro C; Blanch L
    N Engl J Med; 2019 Aug; 381(8):785-786. PubMed ID: 31433932
    [No Abstract]   [Full Text] [Related]  

  • 18. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    Yoshida T; Kavanagh BP; Brochard L
    N Engl J Med; 2019 Aug; 381(8):786-787. PubMed ID: 31433933
    [No Abstract]   [Full Text] [Related]  

  • 19. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    Gallo de Moraes A; El-Yafawi R; Oeckler RA
    N Engl J Med; 2019 Aug; 381(8):787. PubMed ID: 31433934
    [No Abstract]   [Full Text] [Related]  

  • 20. Pilot Feasibility Study of Therapeutic Hypothermia for Moderate to Severe Acute Respiratory Distress Syndrome.
    Slack DF; Corwin DS; Shah NG; Shanholtz CB; Verceles AC; Netzer G; Jones KM; Brown CH; Terrin ML; Hasday JD
    Crit Care Med; 2017 Jul; 45(7):1152-1159. PubMed ID: 28406814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.